Vaccinex (VCNX) Competitors $0.51 0.00 (0.00%) As of 10/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. TTNP, SNOA, CPHI, CERO, SXTP, PBM, LIAN, CMND, AEZS, and KTTAShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Titan Pharmaceuticals (TTNP), Sonoma Pharmaceuticals (SNOA), China Pharma (CPHI), CERo Therapeutics (CERO), 60 Degrees Pharmaceuticals (SXTP), Psyence Biomedical (PBM), LianBio (LIAN), Clearmind Medicine (CMND), Aeterna Zentaris (AEZS), and Pasithea Therapeutics (KTTA). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Its Competitors Titan Pharmaceuticals Sonoma Pharmaceuticals China Pharma CERo Therapeutics 60 Degrees Pharmaceuticals Psyence Biomedical LianBio Clearmind Medicine Aeterna Zentaris Pasithea Therapeutics Vaccinex (NASDAQ:VCNX) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Is VCNX or TTNP more profitable? Vaccinex's return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Titan Pharmaceuticals N/A -108.60%-95.64% Do insiders and institutionals hold more shares of VCNX or TTNP? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Comparatively, 0.7% of Titan Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility & risk, VCNX or TTNP? Vaccinex has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Does the media prefer VCNX or TTNP? In the previous week, Titan Pharmaceuticals had 3 more articles in the media than Vaccinex. MarketBeat recorded 3 mentions for Titan Pharmaceuticals and 0 mentions for Vaccinex. Titan Pharmaceuticals' average media sentiment score of 1.12 beat Vaccinex's score of 0.00 indicating that Titan Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Titan Pharmaceuticals Positive Do analysts rate VCNX or TTNP? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaccinex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Titan Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has stronger valuation and earnings, VCNX or TTNP? Titan Pharmaceuticals has lower revenue, but higher earnings than Vaccinex. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K3.42-$20.25M-$48.27-0.01Titan PharmaceuticalsN/AN/A-$4.71M-$2.95-2.01 SummaryTitan Pharmaceuticals beats Vaccinex on 7 of the 12 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.33M$1.03B$6.15B$10.63BDividend YieldN/A4.84%5.66%4.69%P/E Ratio-0.011.2585.8827.64Price / Sales3.4230.85624.96198.90Price / CashN/A17.6438.3262.20Price / Book-0.207.3613.016.79Net Income-$20.25M-$7.96M$3.30B$275.88M7 Day Performance-20.30%30.95%3.71%1.84%1 Month Performance-7.25%28.00%10.70%8.84%1 Year Performance-74.50%-6.57%84.17%36.10% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex0.7508 of 5 stars$0.51flatN/A-71.7%$1.33M$388K-0.0140TTNPTitan Pharmaceuticals0.8285 of 5 stars$4.79+12.4%N/A+18.5%$6.37MN/A-1.6210Positive NewsSNOASonoma Pharmaceuticals0.5361 of 5 stars$3.88-1.5%N/A+53.1%$6.36M$14.29M-1.58180News CoverageAnalyst ForecastCPHIChina PharmaN/A$1.95-0.5%N/A-91.7%$6.36M$4.40M0.00250CEROCERo Therapeutics3.1176 of 5 stars$5.09-3.0%$45.00+784.1%-98.0%$6.16MN/A0.008Analyst ForecastSXTP60 Degrees Pharmaceuticals2.4748 of 5 stars$1.48-3.9%$3.00+102.7%-69.2%$6.07M$641.41K-0.033News CoverageAnalyst ForecastGap DownPBMPsyence Biomedical1.5337 of 5 stars$3.20+0.3%N/A-93.3%$5.96MN/A0.00N/AAnalyst ForecastGap DownLIANLianBioN/A$0.05+0.2%N/A-81.0%$5.85MN/A-0.07110CMNDClearmind Medicine1.2675 of 5 stars$1.03+2.5%N/A-31.3%$5.60MN/A-1.35N/AAEZSAeterna ZentarisN/A$3.08+1.3%N/A-16.8%$5.52M$2.37M-0.2120KTTAPasithea Therapeutics1.047 of 5 stars$0.73+1.6%N/A-83.8%$5.45MN/A-0.103Positive News Related Companies and Tools Related Companies TTNP Competitors SNOA Competitors CPHI Competitors CERO Competitors SXTP Competitors PBM Competitors LIAN Competitors CMND Competitors AEZS Competitors KTTA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredHow to Cash In on Trump’s Digital Current - Move By This ThursdayBitcoin Breakout: What Most Investors Are Missing Washington just approved more crypto legislation in 90 da...Investors Alley | SponsoredTesla’s $30 trillion pivotElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
